ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0870

Same Model, Different Results: Vendor and Microbiome Influence Reproducibility in Collagen Induced Arthritis

Brenda Seymour1, Brendan Allen2 and Kristine Kuhn3, 1University of Colorado School of Medicine, Denver, CO, 2University of Colorado School of Medicine, Aurora, CO, 32022 - 2023 / Adult/ University of Colorado, Aurora, CO

Meeting: ACR Convergence 2025

Keywords: Animal Model, Collagen-Induced Arthritis, microbiome, Mouse Models, RA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: Rheumatoid Arthritis – Animal Models (0867–0872)

Session Type: Abstract Session

Session Time: 10:45AM-11:00AM

Background/Purpose: Although collagen-induced arthritis (CIA) in mice is a useful tool for studying inflammatory arthritis, it is a highly variable model with inconsistent disease severity and penetrance across studies. Previous studies have shown that CIA severity and penetrance vary by mouse strain, sex, and source of type II collagen. Furthermore, we and others have shown that CIA development is microbiome-dependent. Despite these findings, the extent to which distinct microbiome compositions affect CIA outcomes has not been well studied. As such, microbiome variation between mouse vendors, housing facilities, and even over time has the potential to negatively impact the reproducibility of CIA studies. We therefore performed a head-to-head comparison of CIA in DBA/1 mice obtained from three different vendors and compared CIA outcomes to microbiome composition.

Methods: 7-week-old male DBA/1 mice were purchased from The Jackson Laboratory (Jax), Envigo, or Taconic. Mice from the three vendors simultaneously were injected intradermally at the base of the tail with 200µg bovine CII (Elastin) emulsified in 50µl complete Freund’s adjuvant (CFA, Sigma) on days 0 and 21. Disease severity was assessed every other day starting at day 21. Serum and fecal pellets were collected weekly throughout the experiment. Serum cytokines and autoantibodies were measured by ELISA; 16S rRNA sequencing was performed by the CU Anschutz Mucosal Immunobiology Core.

Results: CIA severity was significantly higher in Envigo and Taconic mice compared to Jax mice (Figure 1). While Taconic and Envigo mice had nearly identical mean CIA severity scores, there was a higher degree of score variability within the Taconic mice. Despite significant differences in CIA severity between the Jax, Envigo, and Taconic groups, there were no significant differences in total CII-IgG levels at day 28, nor CII-IgG isotypes (IgG1, IgG2a, IgG2b). We also observed significant differences in microbiome alpha and beta diversity between the three groups. Finally, we identified 7 genera that significantly correlated with CIA score (Figure 2). Candidatus arthromitus (also known as segmented filamentous bacteria) had the strongest positive correlation with CIA severity, while butyrate-producing Butyricoccaceae had a significant negative correlation with CIA severity.

Conclusion: Our findings reveal that the vendor source of mice significantly impacts CIA severity, independent of systemic autoantibody and cytokine levels. Several bacterial taxa (e.g. Candidatus arthromitus, Butyrococcaceae) may play a key role in disease severity differences. This highlights a critical but often overlooked source of variability that may contribute to irreproducibility across preclinical arthritis studies. Moving forward, intentional selection of mouse source—and consideration of microbiota as a key experimental variable—will be essential for enhancing the reproducibility of the CIA model.

Supporting image 1Figure 1. CIA was induced in 7-week old male DBA/1 mice from Envigo, Jax, and Taconic. Arthritis severity was scored every other day starting at day 21. Data shown are represented as mean (symbol) ± SEM (error bars). Two-way ANOVA with Tukey correction for multiple comparisons were performed.

Supporting image 2Figure 2. Fecal microbiome on CIA day 35 was assessed by 16S rRNA sequencing. The top 25 genera that correlate (spearman rank) with CIA severity were plotted. Bars represent correlation coefficient, with darker shading representing increased absolute value of the correlation efficient. * denotes FDR < 0.1.


Disclosures: B. Seymour: None; B. Allen: None; K. Kuhn: Solarea, 2.

To cite this abstract in AMA style:

Seymour B, Allen B, Kuhn K. Same Model, Different Results: Vendor and Microbiome Influence Reproducibility in Collagen Induced Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/same-model-different-results-vendor-and-microbiome-influence-reproducibility-in-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/same-model-different-results-vendor-and-microbiome-influence-reproducibility-in-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology